These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6344102)

  • 1. Epoprostenol (prostacyclin,PGI2) increases apparent liver blood flow in man.
    Hassan S; Pickles H
    Prostaglandins Leukot Med; 1983 Apr; 10(4):449-54. PubMed ID: 6344102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.
    Warrington SJ; Smith PR; O'Grady J
    Eur J Cardiol; 1980; 12(2):73-80. PubMed ID: 7002563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of epoprostenol (prostacyclin, PGI2) on cerebral blood flow in man.
    Brown MM; Pickles H
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):1033-6. PubMed ID: 6816907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
    Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
    Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostacyclin on hepatic vasculature and metabolism of renin in conscious dogs.
    Echtenkamp SF; Davis JO; Freeman RH; Dietz JR; Villarreal D
    Am J Physiol; 1982 Oct; 243(4):H584-9. PubMed ID: 6751098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intravenous epoprostenol (prostacyclin, PGI2) on cerebral blood flow and cardiac output in man.
    Cook PJ; Maidment CG; Dandona P; Hutton RA; James IM
    Br J Clin Pharmacol; 1983 Dec; 16(6):707-11. PubMed ID: 6362696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin, indomethacin and the cerebral circulation.
    Pickard J; Tamura A; Stewart M; McGeorge A; Fitch W
    Brain Res; 1980 Sep; 197(2):425-31. PubMed ID: 6773615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin on cerebral blood flow, carbon dioxide reactivity and the response to epoprostenol (prostacyclin) infusion in man.
    Pickles H; Brown MM; Thomas M; Hewazy AH; Redmond S; Zilkha E; Marshall J
    J Neurol Neurosurg Psychiatry; 1984 Jan; 47(1):51-5. PubMed ID: 6420520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts.
    Scholtholt J; Birringer H; Fiedler VB; Schölkens B
    Basic Res Cardiol; 1981; 76(3):313-27. PubMed ID: 7023464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and platelet effects in man of BW 245C, a stable mimic of epoprostenol (PGI2).
    Orchard MA; Ritter JM; Shepherd GL; Lewis PJ
    Br J Clin Pharmacol; 1983 May; 15(5):509-11. PubMed ID: 6344895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.
    Pickles H; O'Grady J
    Br J Clin Pharmacol; 1982 Aug; 14(2):177-85. PubMed ID: 7049212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin effect on cardiovascular system in man evaluated by echocardiography.
    Triulzi MO; Cirino D; Gentile F; Balice G; Aguggini G; Maggi GC
    Prostaglandins Med; 1981 Dec; 7(6):501-10. PubMed ID: 7034023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasodilation: interactions between prostacyclin and adenosine.
    Blass KE; Förster W; Zehl U
    Br J Pharmacol; 1980 Aug; 69(4):555-9. PubMed ID: 7002243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic changes induced by prostacyclin in man.
    Szczeklik J; Szczeklik A; Nizankowski R
    Br Heart J; 1980 Sep; 44(3):254-8. PubMed ID: 7000101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin effect on blood pressure in pig with aortic obstruction.
    Triulzi MO; Clement MG; Celsi A; Aguggini G
    Prostaglandins Med; 1981 Oct; 7(4):281-91. PubMed ID: 7031726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin effects on renal hemodynamic and excretory functions in the rat.
    Baer PG; Kauker ML; McGiff JC
    J Pharmacol Exp Ther; 1979 Feb; 208(2):294-7. PubMed ID: 368314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.